BioRestorative Therapies, Inc. - Common Stock (NQ:BRTX)

1.040 -0.060 (-5.45%)

Streaming Delayed Price Updated: 3:36 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	53,935
Open	1.080
Bid (Size)	1.000 (400)
Ask (Size)	1.080 (100)
Prev. Close	1.100
Today's Range	1.000 - 1.080
52wk Range	1.040 - 2.550
Shares Outstanding	8,876,242
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 20, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Thursday's session. ↗

November 20, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Performance

YTD	-30.2%	-30.2%
1 Month	-33.8%	-33.8%
3 Month	-31.1%	-31.1%
6 Month	-41.9%	-41.9%
1 Year	-31.1%	-31.1%

More News

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Earnings Outlook For BioRestorative Therapies ↗

August 11, 2025

Via Benzinga

BioRestorative (BRTX) Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

Earnings Outlook For BioRestorative Therapies ↗

November 11, 2025

Via Benzinga

The trading volume of these stocks is deviating from the norm in today's session. ↗

October 28, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 22, 2025

Via Benzinga

From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain

July 16, 2025

Via NewMediaWire

From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain

July 16, 2025

Via TheNewswire.com

BioRestorative Announces Share Repurchase Program

June 17, 2025

Via PressReach

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

June 13, 2025

Via PressReach

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

June 10, 2025

Via PressReach

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

June 09, 2025

Via PressReach

Uncovering Potential: BioRestorative Therapies's Earnings Preview ↗

May 13, 2025

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies

April 23, 2025

Via NewMediaWire

Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies

April 23, 2025

Via TheNewswire.com

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

April 16, 2025

Via NewMediaWire

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

April 16, 2025

Via TheNewswire.com

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

Frequently Asked Questions

Is BioRestorative Therapies, Inc. - Common Stock publicly traded?

Yes, BioRestorative Therapies, Inc. - Common Stock is publicly traded.

What exchange does BioRestorative Therapies, Inc. - Common Stock trade on?

BioRestorative Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioRestorative Therapies, Inc. - Common Stock?

The ticker symbol for BioRestorative Therapies, Inc. - Common Stock is BRTX on the Nasdaq Stock Market

What is the current price of BioRestorative Therapies, Inc. - Common Stock?

The current price of BioRestorative Therapies, Inc. - Common Stock is 1.040

When was BioRestorative Therapies, Inc. - Common Stock last traded?

The last trade of BioRestorative Therapies, Inc. - Common Stock was at 11/24/25 03:36 PM ET

What is the market capitalization of BioRestorative Therapies, Inc. - Common Stock?

The market capitalization of BioRestorative Therapies, Inc. - Common Stock is 9.23M

How many shares of BioRestorative Therapies, Inc. - Common Stock are outstanding?

BioRestorative Therapies, Inc. - Common Stock has 9M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.